[1] Chou M W, Fu P P.Formation of DHP-derived DNA adducts in vivo from dietary supplements and Chinese herbal plant containing carcinogenic pyrrolizidine alkaloids[J]. Toxicology & Industrial Health, 2006, 22(8): 321-327. [2] 孙潇翔, 向娥, 邱帅凯, 等. 吡咯里西啶生物碱毒性作用研究进展[J]. 中国药物警戒,2019, 16(2): 76-80. [3] Mattocks A R.Chemistry and Toxicity of Pyrrolizldlne Alkaloid [M]. London: Academic Press Inc, 1986. [4] Coulomber R A Jr, Drew G L, Stermitz F R. Pyrrolizidine alkaloids crosslink DNA with actin[J]. Toxicology and Applied Pharmacology, 1999, 154(2): 198-202. [5] 彭静,闫心丽,王琳,等. 吡咯里西啶类生物碱小鼠腹腔注射急性毒性的QSAR研究[J]. 数理医药学杂志,2012,25(2):127-129. [6] 高志祥.四逆汤化学成分的测定及毒性分析[EB/OL]. (2011-05-20)[2019-04-06].互联网文档资源, http://m.book118.com. [7] 李佐静,王琳,闫心丽,等. 基于偏最小二乘法的乌头碱类化合物毒性的定量构效关系研究[J]. 计算机与应用化学,2011,28(6): 765-768. [8] 项彦华, 孙淑娜, 王磊, 等. 近红外光谱技术快速检测银杏叶中指标成分含量的研究[J]. 中国药物警戒, 2015, 12(12): 744-747. [9] National Institutes of Health. National Library of Medicine [EB/OL].(2010-12-30)[2019-04-06].http://sis.nlm.nih.gov/index.html. [10] 高惠璇. 应用多元统计分析[M]. 北京:北京大学出版社,2005. [11] Errol Z.Historical perspective on the development of the genetic toxicity test battery in the United States[J]. Environmental and Molecular Mutagenesis, 2010, 51(8-9): 781-91. [12] Yun J W, Kim S H, Kim Y S, et al.Preclinical study of safety of Dendropanax morbifera Leveille leaf extract: General and genetic toxicology[J]. J Ethnopharmacol, 2019, Doi: 10.1016/j.jep.2019. 111874. [13] Lavanderos M A, Cayún J P, Roco , et al. Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients[J]. Front Pharmacol,2019, Doi: 10.3389/fphar.2019.00206. [14] Cho R, Mi K, Hwan L, et al.Acute and genetic toxicity of GS-E3D, a new pectin lyase-modified red ginseng extract[J]. Regulatory Toxicology and Pharmacology, 2019, 104(6): 157-162. [15] 徐男,孙蓉,李晓宇, 等. 基于“效-毒”相关模式的柴胡注射液质量研究与思考[J]. 中国药物警戒,2015,12(4): 200-202. [16] 孙也之. QSAR模型的构建、应用与研究[C]//中国医科大学硕士论文,沈阳:2009. [17] 温艳清,王琳,赵楠,等. 代谢组学技术在中药毒性机制及解毒机制研究中的应用[J]. 中国药物警戒,2018, 15(5): 280-285. [18] Kennedy T.Managing the drug discovery/development interface[J]. Drug Discovery Today, 1997, 2(10): 436-444. [19] Wang M, Liang J, Kamara M O, et al.A comprehensive in silicon method to study the QSTR of the aconitine alkaloids for designing the novel drugs[J]. Molecules, 2018, 23(9): 2385. |